Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Founder and CEO of Brooks Bell Inc.
Managing Partner at Pappas Ventures
Co-Founder and CEO, Wetpaint
Lux Capital co-founder and managing partner Josh Wolfe separates the grain from the chaff in a presentation on nanotechnology, and what manufacturing at atomic-level precision means in a variety of industries. A reception and networking begins at 5:30 pm, and online registration is here.